| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 2.16e-05 | 9 | 16 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 3.95e-05 | 12 | 16 | 2 | GO:0008519 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.26e-04 | 125 | 16 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 1.51e-04 | 23 | 16 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 1.93e-04 | 26 | 16 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | symporter activity | 2.17e-04 | 150 | 16 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.21e-04 | 151 | 16 | 3 | GO:0008509 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 3.18e-04 | 171 | 16 | 3 | GO:0015103 | |
| GeneOntologyMolecularFunction | channel activity | 6.68e-04 | 525 | 16 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.73e-04 | 526 | 16 | 4 | GO:0022803 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.56e-03 | 296 | 16 | 3 | GO:0015291 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 2.60e-03 | 758 | 16 | 4 | GO:0015318 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 4.00e-03 | 119 | 16 | 2 | GO:0015294 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 6.02e-03 | 477 | 16 | 3 | GO:0022804 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 7.73e-03 | 167 | 16 | 2 | GO:0015079 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.25e-02 | 1180 | 16 | 4 | GO:0022857 | |
| GeneOntologyMolecularFunction | transporter activity | 1.68e-02 | 1289 | 16 | 4 | GO:0005215 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 4.38e-05 | 13 | 16 | 2 | GO:0072488 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 8.29e-05 | 112 | 16 | 3 | GO:1902476 | |
| GeneOntologyBiologicalProcess | chloride transport | 1.23e-04 | 128 | 16 | 3 | GO:0006821 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.41e-04 | 134 | 16 | 3 | GO:0098661 | |
| GeneOntologyBiologicalProcess | chloride ion homeostasis | 1.67e-04 | 25 | 16 | 2 | GO:0055064 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 2.09e-04 | 153 | 16 | 3 | GO:0098656 | |
| GeneOntologyBiologicalProcess | monoatomic anion homeostasis | 2.11e-04 | 28 | 16 | 2 | GO:0055081 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 3.37e-04 | 180 | 16 | 3 | GO:0015698 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 3.53e-04 | 183 | 16 | 3 | GO:0006820 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 3.70e-04 | 37 | 16 | 2 | GO:0055075 | |
| GeneOntologyBiologicalProcess | cell volume homeostasis | 4.77e-04 | 42 | 16 | 2 | GO:0006884 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 6.88e-04 | 230 | 16 | 3 | GO:0098739 | |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 7.04e-04 | 51 | 16 | 2 | GO:1990573 | |
| GeneOntologyCellularComponent | intermediate filament | 8.04e-07 | 227 | 17 | 5 | GO:0005882 | |
| GeneOntologyCellularComponent | keratin filament | 9.90e-07 | 97 | 17 | 4 | GO:0045095 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 1.66e-06 | 263 | 17 | 5 | GO:0045111 | |
| GeneOntologyCellularComponent | supramolecular fiber | 2.29e-04 | 1179 | 17 | 6 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 2.38e-04 | 1187 | 17 | 6 | GO:0099081 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 5.84e-04 | 899 | 17 | 5 | GO:0099513 | |
| Domain | KCL_cotranspt | 4.12e-06 | 4 | 16 | 2 | IPR000076 | |
| Domain | Keratin_B2 | 5.00e-06 | 40 | 16 | 3 | PF01500 | |
| Domain | SLC12A_fam | 1.44e-05 | 7 | 16 | 2 | IPR004842 | |
| Domain | KAP | 1.55e-05 | 58 | 16 | 3 | IPR002494 | |
| Domain | SLC12_C | 1.92e-05 | 8 | 16 | 2 | IPR018491 | |
| Domain | SLC12 | 1.92e-05 | 8 | 16 | 2 | PF03522 | |
| Domain | AA-permease/SLC12A_dom | 1.57e-04 | 22 | 16 | 2 | IPR004841 | |
| Domain | AA_permease | 1.57e-04 | 22 | 16 | 2 | PF00324 | |
| Domain | Keratin_B2_2 | 5.01e-04 | 39 | 16 | 2 | PF13885 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 2.21e-05 | 7 | 15 | 2 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 2.21e-05 | 7 | 15 | 2 | MM15081 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 9.34e-05 | 238 | 15 | 4 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.11e-04 | 249 | 15 | 4 | M5988 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.86e-04 | 108 | 15 | 3 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.91e-04 | 109 | 15 | 3 | MM15074 | |
| Pathway | REACTOME_KERATINIZATION | 5.18e-04 | 153 | 15 | 3 | MM15343 | |
| Pathway | REACTOME_KERATINIZATION | 1.43e-03 | 217 | 15 | 3 | M27640 | |
| Pubmed | 1.60e-08 | 11 | 17 | 3 | 14962103 | ||
| Pubmed | 5.41e-08 | 16 | 17 | 3 | 15028290 | ||
| Pubmed | Differences in the large extracellular loop between the K(+)-Cl(-) cotransporters KCC2 and KCC4. | 2.25e-07 | 2 | 17 | 2 | 20516068 | |
| Pubmed | Molecular, functional, and genomic characterization of human KCC2, the neuronal K-Cl cotransporter. | 2.25e-07 | 2 | 17 | 2 | 12106695 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 12637262 | ||
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 11395011 | ||
| Pubmed | The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters. | 6.29e-06 | 8 | 17 | 2 | 24393035 | |
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 6.29e-06 | 8 | 17 | 2 | 21613606 | |
| Pubmed | Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold. | 8.08e-06 | 9 | 17 | 2 | 14532115 | |
| Pubmed | 8.08e-06 | 9 | 17 | 2 | 19323993 | ||
| Pubmed | Rare independent mutations in renal salt handling genes contribute to blood pressure variation. | 5.16e-05 | 22 | 17 | 2 | 18391953 | |
| Pubmed | 1.73e-04 | 40 | 17 | 2 | 12359730 | ||
| Pubmed | 2.54e-04 | 258 | 17 | 3 | 10830953 | ||
| Interaction | KRTAP4-4 interactions | 4.25e-07 | 81 | 16 | 4 | int:KRTAP4-4 | |
| Interaction | LCE3B interactions | 6.10e-06 | 46 | 16 | 3 | int:LCE3B | |
| Interaction | LCE3C interactions | 1.91e-05 | 67 | 16 | 3 | int:LCE3C | |
| Interaction | LCE1E interactions | 1.99e-05 | 68 | 16 | 3 | int:LCE1E | |
| Interaction | ZNF433 interactions | 2.65e-05 | 10 | 16 | 2 | int:ZNF433 | |
| Interaction | LCE1C interactions | 2.90e-05 | 77 | 16 | 3 | int:LCE1C | |
| Interaction | POM121L8P interactions | 3.24e-05 | 11 | 16 | 2 | int:POM121L8P | |
| Interaction | C17orf50 interactions | 3.88e-05 | 12 | 16 | 2 | int:C17orf50 | |
| Interaction | LCE1B interactions | 3.90e-05 | 85 | 16 | 3 | int:LCE1B | |
| Interaction | LCE2C interactions | 4.32e-05 | 88 | 16 | 3 | int:LCE2C | |
| Interaction | ZNF559 interactions | 4.59e-05 | 13 | 16 | 2 | int:ZNF559 | |
| Interaction | LCE1F interactions | 4.94e-05 | 92 | 16 | 3 | int:LCE1F | |
| Interaction | KRTAP5-6 interactions | 5.27e-05 | 94 | 16 | 3 | int:KRTAP5-6 | |
| Interaction | SLC12A5 interactions | 1.23e-04 | 21 | 16 | 2 | int:SLC12A5 | |
| Interaction | CATSPER1 interactions | 1.26e-04 | 126 | 16 | 3 | int:CATSPER1 | |
| Interaction | MOBP interactions | 1.48e-04 | 23 | 16 | 2 | int:MOBP | |
| Interaction | ZNF587 interactions | 1.54e-04 | 135 | 16 | 3 | int:ZNF587 | |
| Interaction | SPATA3 interactions | 1.61e-04 | 24 | 16 | 2 | int:SPATA3 | |
| Interaction | KRTAP9-3 interactions | 1.72e-04 | 140 | 16 | 3 | int:KRTAP9-3 | |
| Interaction | SLC23A1 interactions | 1.90e-04 | 26 | 16 | 2 | int:SLC23A1 | |
| Interaction | ZNF439 interactions | 2.05e-04 | 27 | 16 | 2 | int:ZNF439 | |
| Interaction | ZNF286A interactions | 2.54e-04 | 30 | 16 | 2 | int:ZNF286A | |
| Interaction | TNP2 interactions | 2.71e-04 | 31 | 16 | 2 | int:TNP2 | |
| Interaction | CREB5 interactions | 2.74e-04 | 164 | 16 | 3 | int:CREB5 | |
| Interaction | ZNF329 interactions | 2.89e-04 | 32 | 16 | 2 | int:ZNF329 | |
| Interaction | BCL6B interactions | 3.08e-04 | 33 | 16 | 2 | int:BCL6B | |
| Interaction | KRTAP9-4 interactions | 3.08e-04 | 33 | 16 | 2 | int:KRTAP9-4 | |
| Interaction | SLC6A20 interactions | 3.27e-04 | 34 | 16 | 2 | int:SLC6A20 | |
| Interaction | ZNF440 interactions | 4.53e-04 | 40 | 16 | 2 | int:ZNF440 | |
| Interaction | ZNF264 interactions | 4.76e-04 | 41 | 16 | 2 | int:ZNF264 | |
| Interaction | KRTAP5-9 interactions | 5.12e-04 | 203 | 16 | 3 | int:KRTAP5-9 | |
| Interaction | AEN interactions | 6.26e-04 | 47 | 16 | 2 | int:AEN | |
| Interaction | KRTAP1-5 interactions | 6.53e-04 | 48 | 16 | 2 | int:KRTAP1-5 | |
| Interaction | NBPF19 interactions | 7.64e-04 | 233 | 16 | 3 | int:NBPF19 | |
| Interaction | FBXO34 interactions | 8.56e-04 | 55 | 16 | 2 | int:FBXO34 | |
| Interaction | ZNF124 interactions | 9.85e-04 | 59 | 16 | 2 | int:ZNF124 | |
| Interaction | CTSZ interactions | 9.85e-04 | 59 | 16 | 2 | int:CTSZ | |
| Interaction | ZSCAN26 interactions | 9.85e-04 | 59 | 16 | 2 | int:ZSCAN26 | |
| Interaction | LCE3E interactions | 1.02e-03 | 60 | 16 | 2 | int:LCE3E | |
| Interaction | ZNF572 interactions | 1.05e-03 | 61 | 16 | 2 | int:ZNF572 | |
| Interaction | KRTAP5-2 interactions | 1.09e-03 | 62 | 16 | 2 | int:KRTAP5-2 | |
| Interaction | KRTAP5-4 interactions | 1.12e-03 | 63 | 16 | 2 | int:KRTAP5-4 | |
| Interaction | KRTAP12-1 interactions | 1.12e-03 | 63 | 16 | 2 | int:KRTAP12-1 | |
| Interaction | KRTAP10-11 interactions | 1.16e-03 | 64 | 16 | 2 | int:KRTAP10-11 | |
| Interaction | NPDC1 interactions | 1.19e-03 | 65 | 16 | 2 | int:NPDC1 | |
| Interaction | KRTAP5-11 interactions | 1.23e-03 | 66 | 16 | 2 | int:KRTAP5-11 | |
| Interaction | CRCT1 interactions | 1.23e-03 | 66 | 16 | 2 | int:CRCT1 | |
| Interaction | KRTAP5-3 interactions | 1.23e-03 | 66 | 16 | 2 | int:KRTAP5-3 | |
| Interaction | NR4A3 interactions | 1.34e-03 | 69 | 16 | 2 | int:NR4A3 | |
| Interaction | LCE2A interactions | 1.34e-03 | 69 | 16 | 2 | int:LCE2A | |
| Interaction | LCE1D interactions | 1.38e-03 | 70 | 16 | 2 | int:LCE1D | |
| Interaction | KRTAP5-7 interactions | 1.42e-03 | 71 | 16 | 2 | int:KRTAP5-7 | |
| Interaction | LCE3D interactions | 1.50e-03 | 73 | 16 | 2 | int:LCE3D | |
| Interaction | LCE2D interactions | 1.54e-03 | 74 | 16 | 2 | int:LCE2D | |
| Interaction | FCHO1 interactions | 1.59e-03 | 75 | 16 | 2 | int:FCHO1 | |
| Interaction | WT1 interactions | 1.63e-03 | 76 | 16 | 2 | int:WT1 | |
| Interaction | LCE3A interactions | 1.63e-03 | 76 | 16 | 2 | int:LCE3A | |
| Interaction | KRTAP4-5 interactions | 1.63e-03 | 76 | 16 | 2 | int:KRTAP4-5 | |
| Interaction | KRTAP3-2 interactions | 1.76e-03 | 79 | 16 | 2 | int:KRTAP3-2 | |
| Interaction | SMCP interactions | 1.76e-03 | 79 | 16 | 2 | int:SMCP | |
| Interaction | LCE4A interactions | 1.80e-03 | 80 | 16 | 2 | int:LCE4A | |
| Interaction | LCE2B interactions | 1.85e-03 | 81 | 16 | 2 | int:LCE2B | |
| Interaction | POU4F2 interactions | 1.94e-03 | 83 | 16 | 2 | int:POU4F2 | |
| Interaction | LCE1A interactions | 1.98e-03 | 84 | 16 | 2 | int:LCE1A | |
| Interaction | HPCAL1 interactions | 2.17e-03 | 88 | 16 | 2 | int:HPCAL1 | |
| Interaction | KRTAP10-6 interactions | 2.17e-03 | 88 | 16 | 2 | int:KRTAP10-6 | |
| Interaction | LCE5A interactions | 2.27e-03 | 90 | 16 | 2 | int:LCE5A | |
| Interaction | KRTAP4-11 interactions | 2.37e-03 | 92 | 16 | 2 | int:KRTAP4-11 | |
| Interaction | KRTAP26-1 interactions | 2.48e-03 | 94 | 16 | 2 | int:KRTAP26-1 | |
| Interaction | CHRD interactions | 2.48e-03 | 94 | 16 | 2 | int:CHRD | |
| Interaction | ZNF785 interactions | 2.53e-03 | 95 | 16 | 2 | int:ZNF785 | |
| Interaction | HOXA1 interactions | 2.58e-03 | 356 | 16 | 3 | int:HOXA1 | |
| Interaction | SHFL interactions | 2.63e-03 | 97 | 16 | 2 | int:SHFL | |
| Interaction | FAM76B interactions | 2.74e-03 | 99 | 16 | 2 | int:FAM76B | |
| Interaction | KRTAP9-8 interactions | 2.80e-03 | 100 | 16 | 2 | int:KRTAP9-8 | |
| Interaction | KRTAP2-4 interactions | 2.85e-03 | 101 | 16 | 2 | int:KRTAP2-4 | |
| Interaction | NOTCH2NLA interactions | 3.13e-03 | 381 | 16 | 3 | int:NOTCH2NLA | |
| Interaction | ECE1 interactions | 3.25e-03 | 108 | 16 | 2 | int:ECE1 | |
| Interaction | SPRY1 interactions | 3.43e-03 | 111 | 16 | 2 | int:SPRY1 | |
| Interaction | KRTAP10-8 interactions | 3.61e-03 | 401 | 16 | 3 | int:KRTAP10-8 | |
| Interaction | CBLB interactions | 3.68e-03 | 115 | 16 | 2 | int:CBLB | |
| Interaction | SLC12A4 interactions | 4.60e-03 | 129 | 16 | 2 | int:SLC12A4 | |
| Interaction | SLC12A7 interactions | 4.81e-03 | 132 | 16 | 2 | int:SLC12A7 | |
| Interaction | KRTAP4-2 interactions | 4.81e-03 | 132 | 16 | 2 | int:KRTAP4-2 | |
| Interaction | PRKAG1 interactions | 5.93e-03 | 147 | 16 | 2 | int:PRKAG1 | |
| Interaction | TRIM42 interactions | 6.09e-03 | 149 | 16 | 2 | int:TRIM42 | |
| Interaction | KRTAP9-2 interactions | 6.09e-03 | 149 | 16 | 2 | int:KRTAP9-2 | |
| Interaction | SPRY2 interactions | 6.33e-03 | 152 | 16 | 2 | int:SPRY2 | |
| Cytoband | 21q22.3 | 1.40e-05 | 128 | 17 | 3 | 21q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | 3.43e-04 | 377 | 17 | 3 | chr21q22 | |
| GeneFamily | Keratin associated proteins | 1.19e-06 | 109 | 14 | 4 | 619 | |
| GeneFamily | Solute carriers | 1.89e-04 | 395 | 14 | 4 | 752 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.Sp, TCRd+ Vg2+ CD44-, Spleen, avg-3 | 9.32e-05 | 386 | 14 | 4 | GSM605787_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | 1.21e-04 | 811 | 14 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | 1.39e-04 | 428 | 14 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.20e-05 | 146 | 17 | 3 | 522c32103c24fc26836bb5b642083904682d9292 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.53e-05 | 153 | 17 | 3 | 7518187a5fbf6c0881182dc79bd37c2d49f92b2e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.53e-05 | 153 | 17 | 3 | 93d36723f01c2df39feebf20f3eba5b4fb4cdf59 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-05 | 167 | 17 | 3 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 3.59e-05 | 172 | 17 | 3 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | normal-na-Lymphocytic_T-T8_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.39e-05 | 184 | 17 | 3 | 4a81190b36d197736663e6177d3b76c1cb6282d6 | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 4.46e-05 | 185 | 17 | 3 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | facs-Lung-EPCAM-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 186 | 17 | 3 | 7c4eb769574f9f32753cea1cc38c711dabba88b9 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 4.60e-05 | 187 | 17 | 3 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | ASK440-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.75e-05 | 189 | 17 | 3 | 868a387d19eb02bf41933e786b7d23e920a5d433 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-05 | 190 | 17 | 3 | b772a5d281fe016f259ddda80d6f33d949dcac2b | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.90e-05 | 191 | 17 | 3 | 29ce21c6e810edd51f13e0fb1083cd44bd57b1d4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 191 | 17 | 3 | 326b4541069efedc8ab409f85bb11f77346dda90 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 191 | 17 | 3 | 1a2d5fec2bea96da2154b0aed252f1bb35102f6e | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 4.90e-05 | 191 | 17 | 3 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.13e-05 | 194 | 17 | 3 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | Mild-CD8+_T|World / Disease group and Cell class | 5.13e-05 | 194 | 17 | 3 | d64c2efb482bcdef9240977eae1023c4191286e7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.21e-05 | 195 | 17 | 3 | 662b50a2aa97373bf343b88caace9717049c722a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.21e-05 | 195 | 17 | 3 | 9b7157b5e4b81bc35b0e6d9b954279160ea57324 | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD8_T|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.37e-05 | 197 | 17 | 3 | b6ad0a310f557b97d8192a2389692bf3567800cc | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.37e-05 | 197 | 17 | 3 | ece0c17eb68f394b20e588c0b0626d3987a4dbbb | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.37e-05 | 197 | 17 | 3 | 4b6c0e028b9669c102df8e9dc63e284f8d5fd9ee | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.45e-05 | 198 | 17 | 3 | 7608f67959e1cda7b10e57fd3af2f96216ebe7e9 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.62e-05 | 200 | 17 | 3 | 02c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.62e-05 | 200 | 17 | 3 | be9a43acc2f926b9433ab3f018b911b03896a924 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.62e-05 | 200 | 17 | 3 | 20ffb3436d08042f77800513e6ddb3bbc38ae6fe | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 81 | 17 | 2 | 1a22222f2b4ab30f7aa31820029c267a0f2190ec | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.25e-04 | 98 | 17 | 2 | ffe21b3681fdeaf4a8447bd2b13772d03cdd45aa | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.90e-04 | 103 | 17 | 2 | c11bb0238e81a42dad5d7687c9d22474129d803d | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-C1ql2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.44e-04 | 114 | 17 | 2 | f48fd7d378626eb7ef972ff1df87dd6149cb355c | |
| ToppCell | LA-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 8.44e-04 | 114 | 17 | 2 | ca69dddbdc02fa5718c56362649cd4b9b54f94ce | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 8.89e-04 | 117 | 17 | 2 | e13c50260d81e8f2ea99e5c680c9699da246067b | |
| ToppCell | TCGA-Kidney-Solid_Tissue_Normal-Kidney-Kidney_normal_tissue-3|TCGA-Kidney / Sample_Type by Project: Shred V9 | 8.89e-04 | 117 | 17 | 2 | 9a780218d67fa2c0bcdedd22984c4f52bce4b80e | |
| ToppCell | Thalamus-Macroglia-ASTROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.50e-04 | 121 | 17 | 2 | c3a4dfd19b7e8654e859df605d55155b530ad009 | |
| ToppCell | Thalamus-Macroglia-ASTROCYTE-Gja1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.50e-04 | 121 | 17 | 2 | c3efd44bd01c12ef8c7ce4cc351af1540b70a63c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.66e-04 | 122 | 17 | 2 | eae9d94f8510ac0f434942451d55c7260977b178 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.03e-03 | 126 | 17 | 2 | 94bd9cfe982b41a3114885173eab55feb0fbbbae | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-03 | 126 | 17 | 2 | f582c3ed43209dca3538e60062b3edd59bf2ad6b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-C1ql2-Excitatory_Neuron.Slc17a7.C1ql2-Cck_(Dentate_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.08e-03 | 129 | 17 | 2 | 08ecebb7f09d105dfdfd2191fc310910d3baec0f | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_2|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.23e-03 | 138 | 17 | 2 | 05de2cef97c0912fb23f138dd45348f565a14d74 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tfh|Lung / Manually curated celltypes from each tissue | 1.30e-03 | 142 | 17 | 2 | 319812c84fad93276bf093f2ad78db02ae745bf4 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-03 | 143 | 17 | 2 | 92ddc3e3f6ba78dd9daeb272c12503ec2650a874 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-03 | 144 | 17 | 2 | 013223bb2f31eb5bebdbd0908b797d28b96c6f7b | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.36e-03 | 145 | 17 | 2 | 734d85ca7a2e5e040f433cadc5f9be1f25cf2e91 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-03 | 145 | 17 | 2 | 8ba09eb0fd27f25aa90a3ad75d67a9f79f3f4f43 | |
| ToppCell | Epithelial-B_(AT1-AT2-progenitors)|World / shred on cell class and cell subclass (v4) | 1.38e-03 | 146 | 17 | 2 | 4511916904c1fac252cb68e871b782207f8137b3 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_A|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-03 | 146 | 17 | 2 | 0e38e1fa40b1fcd1bb61f7af7cc2206846c192ae | |
| ToppCell | lung-Type_II_Pneumocytes|lung / shred on tissue and cell subclass | 1.40e-03 | 147 | 17 | 2 | 8a3039de45b8087f8319e2e37329acf7278219b7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.40e-03 | 147 | 17 | 2 | 463af96748349c8fec2911b353a7e7e4cb072280 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-03 | 148 | 17 | 2 | cb9365663f9cba35d47b5dd9079f42e88b70d915 | |
| ToppCell | Serous|World / shred by cell class for turbinate | 1.45e-03 | 150 | 17 | 2 | 6a326662d58b0f17d6efa8cc28571f4cbbf57c2d | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-03 | 150 | 17 | 2 | 207fc230d7721149c7afc7970dd56817f52801d8 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.47e-03 | 151 | 17 | 2 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | severe_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 1.49e-03 | 152 | 17 | 2 | ab5a4e47b23d16018642d4c9c7f41b30205edf73 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-03 | 152 | 17 | 2 | 405d19b290232bb3e564d61c0cff0cfdd247bdff | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-03 | 152 | 17 | 2 | 06fa7d8acc8f56de00af9bee17884595b300410e | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 1.49e-03 | 152 | 17 | 2 | f944743f40ff6ed3a7a096dd53e12d3526c67c4d | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.51e-03 | 153 | 17 | 2 | b101cb1bce5db785dab46b6c4f7be9c3efe48b0e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.51e-03 | 153 | 17 | 2 | 487388082bb596809ba1caf9197626b6814792ab | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-03 | 153 | 17 | 2 | 7480522a47e367f8facc4f5d599fbaf0b5ad4007 | |
| ToppCell | RV-17._Lymphocyte|RV / Chamber and Cluster_Paper | 1.51e-03 | 153 | 17 | 2 | e1ea621184014415870e00d511386b8cc3e0833b | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK_CD56bright|World / disease group, cell group and cell class (v2) | 1.51e-03 | 153 | 17 | 2 | aff5c8ab1fb4ebc324cec02cf562b7484bb10db8 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Trm_gut_CD8|bone_marrow / Manually curated celltypes from each tissue | 1.53e-03 | 154 | 17 | 2 | 93145a1bc5712ae664690b03a9e00ce1f92cfc7e | |
| ToppCell | Epithelial-Epithelial-B_(AT1-AT2-progenitors)|Epithelial / shred on cell class and cell subclass (v4) | 1.53e-03 | 154 | 17 | 2 | 770712806e26f73456fb77a81aa4ef8ec78a21ea | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.55e-03 | 155 | 17 | 2 | e2c901d5c9e42d25d7702e5e8fc19b06f7c817be | |
| ToppCell | RV-17._Lymphocyte|World / Chamber and Cluster_Paper | 1.55e-03 | 155 | 17 | 2 | 189276a3b400b2202e6681e23732e6452bfe704e | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-dn_T|COVID-19_Severe / Disease group, lineage and cell class | 1.57e-03 | 156 | 17 | 2 | 83f25683e0f55472b56f915ee176fc05efc33a31 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.57e-03 | 156 | 17 | 2 | 53ded973358e3e48054130131e959f0d1f4ef60f | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-03 | 157 | 17 | 2 | b527e88382c8d21188a0f222b3302523e8816dfc | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-03 | 158 | 17 | 2 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-03 | 158 | 17 | 2 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.61e-03 | 158 | 17 | 2 | c8af8964a140acb2987e3b4906d72c546108d229 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-03 | 158 | 17 | 2 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | severe_COVID-19-NK_CD56bright|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.61e-03 | 158 | 17 | 2 | c2e8d96fc29aa2388b92b4fd81d2726e1f7a053f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-03 | 159 | 17 | 2 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.63e-03 | 159 | 17 | 2 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-03 | 159 | 17 | 2 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-03 | 159 | 17 | 2 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-03 | 160 | 17 | 2 | 55f599df6e3b7a5a505df4b094c834281311d94a | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-03 | 160 | 17 | 2 | 296e53e1e0786346d38db2d4188b9a1c0430627b | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-03 | 160 | 17 | 2 | a494001b1f6dec33624f98fa3c24bad6988d0425 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.67e-03 | 161 | 17 | 2 | b19f82dd98a3064581793711bb70373f18abecd9 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-03 | 162 | 17 | 2 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-03 | 162 | 17 | 2 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-T_entry|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.69e-03 | 162 | 17 | 2 | a27750117e7f16a0bd07cc5f58a56becb39e800b | |
| ToppCell | cellseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-ILC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.69e-03 | 162 | 17 | 2 | 553f91eaba72bcffb733ede45418bbee39c653ab | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Trm_Th1/Th17|bone_marrow / Manually curated celltypes from each tissue | 1.71e-03 | 163 | 17 | 2 | 4d1fd0b1246833723b938eca0cb246e937380e12 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-03 | 164 | 17 | 2 | 7a65c7a6dbe5fb9067f83efafbb7ec8206d79325 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-Activated_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-03 | 164 | 17 | 2 | 24fdea5113d92b96f56b06dd2449910a3c785e69 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.75e-03 | 165 | 17 | 2 | 9ccce713d4122054bf4bef4a7126d90cf9141b84 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-03 | 165 | 17 | 2 | dbe231d00843cae917efd1abea6079ace3b45cdf | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Tfh|bone_marrow / Manually curated celltypes from each tissue | 1.77e-03 | 166 | 17 | 2 | 9ac5267d3a53a96dec9eae3bc01acba4750742c8 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-03 | 166 | 17 | 2 | 3695407e4638f3c18fbff63daba52baa9256c429 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-03 | 167 | 17 | 2 | ed7e785dcd25777f64e0c2596ada4f5a5ea17121 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-03 | 168 | 17 | 2 | 2781dd6b369427a94c5059b44b4c8f023f5f2988 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 1.84e-03 | 169 | 17 | 2 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | COVID-19_Moderate-Treg|World / disease group, cell group and cell class | 1.84e-03 | 169 | 17 | 2 | 27ad11239559b025bef582f89b2a83501d9d3993 | |
| ToppCell | Control-T_cells-Tregs|Control / group, cell type (main and fine annotations) | 1.84e-03 | 169 | 17 | 2 | e1e0983f31ec81b3fad5f9c6140d17f03f81a5dc | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-03 | 169 | 17 | 2 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-03 | 169 | 17 | 2 | 4ac21e8199de4b6917eacadc56fffc6d886ee643 | |
| Drug | Potassium Chloride | 7.86e-06 | 6 | 17 | 2 | DB00761 | |
| Drug | Chlorpropamide [94-20-2]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.21e-05 | 198 | 17 | 4 | 5391_DN | |
| Disease | epilepsy (implicated_via_orthology) | 4.54e-05 | 163 | 13 | 3 | DOID:1826 (implicated_via_orthology) | |
| Disease | mean reticulocyte volume | 3.14e-04 | 799 | 13 | 4 | EFO_0010701 | |
| Disease | femoral neck bone mineral density | 3.26e-03 | 196 | 13 | 2 | EFO_0007785 | |
| Disease | neutrophil count, eosinophil count | 3.84e-03 | 213 | 13 | 2 | EFO_0004833, EFO_0004842 | |
| Disease | asthma | 3.88e-03 | 751 | 13 | 3 | MONDO_0004979 | |
| Disease | neutrophil count, basophil count | 4.24e-03 | 224 | 13 | 2 | EFO_0004833, EFO_0005090 | |
| Disease | granulocyte count | 5.41e-03 | 254 | 13 | 2 | EFO_0007987 | |
| Disease | allergic disease | 5.57e-03 | 258 | 13 | 2 | MONDO_0005271 | |
| Disease | lymphocyte:monocyte ratio | 6.90e-03 | 288 | 13 | 2 | EFO_0600088 | |
| Disease | myeloid white cell count | 7.19e-03 | 937 | 13 | 3 | EFO_0007988 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VTSCMLPRDTSSCMT | 236 | Q15699 | |
| TIVKSSMSCPTVMCD | 466 | Q15283 | |
| LMPDGSCSSALTCSM | 121 | Q6UXI9 | |
| MSSPMPDCTSKCRSL | 1 | Q9P2D0 | |
| MLKVTVPSCSASSCS | 1 | Q16566 | |
| SCSSSSKKSMSCSLT | 321 | P09848 | |
| MCSSKMPCSPSASSL | 1 | G5E9R7 | |
| MAASTMSVCSSACSD | 1 | P60331 | |
| MAACTMSVCSSACSD | 1 | P60370 | |
| MAASTMSICSSACTD | 1 | P60014 | |
| CTCTMLTAISMSAIA | 161 | Q9Y666 | |
| ICCSCTMLTAISMSA | 161 | Q9H2X9 | |
| STKGMPAKSDSSCSM | 656 | Q9HCM1 | |
| MPSACTLVMCSSVES | 31 | P35247 | |
| ATCSSSATLPSMMKC | 341 | P43007 | |
| CAMSMTCPIFSSALN | 151 | Q13336 | |
| MSSKCTTTSDSVCLP | 56 | Q9Y6Q6 |